Trans Fatty Acids.
Research-backed compound with potential health benefits. Raises your bad (LDL) cholesterol, lowers your good (HDL) cholesterol, and promotes systemic inflammation.
Reviewed March 2026
- Category
- Compound
What Trans Fatty Acids is, and what it does.
- Does it work
- No. This is the opposite of a supplement. The only thing it's 'worth' is learning how to spot it on a label so you can avoid it.
- How much to take
- Zero. None. The goal is to consume as close to 0 grams per day as humanly possible. This isn't about moderation.
- Time to feel it
- There is no onset to wait for. Their effect turns up in blood lipid measurements over weeks of steady intake rather than in how a day feels.
- The first dose
- Nothing. It doesn't give you a buzz or a crash. It just silently contributes to arterial plaque and inflammation.
- With regular use
- A significantly increased risk of a major cardiac event. It's a key driver of atherosclerosis (hardening of the arteries). Not a good long-term plan.
- How well tolerated
- Unsafe at any meaningful dose. The scientific consensus is overwhelming. This is one of the worst things you can put in your body.
- How it feels
- You don't feel it. You just see the results on your bloodwork over time: LDL up, HDL down. It's silent damage.
- The overlooked benefit
- The small amount cows make is not the factory molecule. Your body converts part of the vaccenic acid in dairy fat into conjugated linoleic acid.
1 to 2mg a day is where Trans Fatty Acids works.
Source: WHO recommends <1% energy from trans fats; Mozaffarian et al. (2006)
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Trans Fatty Acids is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- blood lipid concentrationsMeta-analysis
- membrane fatty acid compositionRandomised trial
- desaturase enzyme activity in fatty acid conversionIn vitro study
- conversion of vaccenic acid to conjugated linoleic acidAnimal study
Questions people ask about Trans Fatty Acids.
- I thought trans fats were banned?
- The main source, partially hydrogenated oils (PHOs), was banned by the FDA. But companies can petition for specific uses, and products can contain up to 0.5g per serving and still be labeled '0g Trans Fat'.
- How can I spot it on a label?
- Ignore the '0g Trans Fat' on the front. Always read the ingredient list on the back. If you see 'partially hydrogenated oil', it contains trans fat. Put it back.
- What about natural trans fats in meat and dairy?
- They exist in small amounts and are chemically different. The current evidence suggests they aren't nearly as harmful as the artificial kind. The real enemy is the man-made stuff.
- Which foods are the worst offenders?
- Historically: stick margarine, vegetable shortening, commercial baked goods (donuts, cookies, crackers), and many fried foods. They're less common now, but still pop up.
- Is there any safe amount at all?
- No. The American Heart Association and WHO both recommend keeping intake as low as possible, ideally zero. Think of it like asbestos or lead.
- Will eating one cookie with it kill me?
- No, of course not. The damage is cumulative. It's the consistent, long-term intake that hardens your arteries. The goal is to eliminate that steady drip of damage.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Trans isomers are substrates and inhibitors of delta-6 desaturase, the same enzyme that starts the conversion of linoleic acid to longer chain products. When trans fatty acid intake is high, the conversion of the parent essential fatty acid runs slower. This is enzyme kinetics measured in tissue and cell work, not a clinical endpoint.
Both trans isomers and long chain omega-3 fatty acids are esterified into the same membrane phospholipid positions, so the fatty acid profile of a membrane reflects what was eaten. Displacing a straight trans chain with a highly unsaturated one changes membrane fluidity and the pool available to phospholipase release. Membrane composition is a marker, not an outcome.
Arachidonic acid is generated from linoleic acid through the desaturation and elongation sequence that trans isomers compete for, and it is also the direct precursor released for eicosanoid synthesis. A slower upstream conversion shifts the size of the arachidonic acid pool in tissue. What is measured here is precursor availability rather than any downstream clinical effect.
Partially hydrogenated and heated oils still carry residual double bonds that propagate lipid peroxidation chains, and alpha-tocopherol is the chain-breaking antioxidant that terminates them. Frying fats are routinely tocopherol-supplemented for that reason. The role is protection of the oil and of membrane lipid, described as chemistry rather than as a health claim.
Rumen bacteria biohydrogenate dietary linoleic acid through conjugated intermediates, and vaccenic acid, a naturally occurring trans isomer, is the intermediate that mammalian tissue converts back to conjugated linoleic acid. Ruminant trans isomers and conjugated linoleic acid are therefore two points on one microbial pathway. Industrially produced trans isomers arise from a different chemistry.
Dietary trans fatty acids are esterified into the sn-1 and sn-2 positions of phosphatidylcholine and remodelled through the Lands cycle. The acyl composition of that pool sets membrane packing and the substrate available for lipid mediator release. This describes where the molecule goes, not what it does clinically.
Lecithin is used alongside hardened and interesterified fats to control crystal behaviour and viscosity in confectionery and bakery fat systems. It sits with trans-containing fats for a processing reason rather than a nutritional one. Read it as manufacturing context.
Flaxseed oil delivers alpha-linolenic acid, which relies on the delta-6 desaturase step that trans isomers occupy. Where trans intake is substantial, the fraction of alpha-linolenic acid converted onward is smaller. The interaction is at the enzyme, so it does not apply to preformed EPA or DHA.
Nothing specific on file for Trans Fatty Acids. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Trans Fatty Acids actually does.
A trans double bond holds the acyl chain nearly straight, unlike the roughly thirty degree kink of a cis double bond, so trans isomers pack more like saturated chains and raise the melting point of a fat.
Industrial trans fatty acids are formed when hydrogen is added across double bonds of liquid vegetable oil over a metal catalyst and the reaction is stopped part way, leaving isomerised rather than fully saturated bonds. Elaidic acid is the dominant product.
Ruminant trans fatty acids, chiefly vaccenic acid, are formed by bacterial biohydrogenation of dietary unsaturated fats in the rumen and appear in dairy fat and ruminant meat at low percentages.
Mammalian tissue converts a portion of vaccenic acid to conjugated linoleic acid through stearoyl-CoA desaturase, so one naturally occurring trans isomer is a precursor to another fatty acid.
Where Trans Fatty Acids comes from.
There are two ways these end up in food. A factory can bubble hydrogen through liquid oil to make it solid and stop the process halfway, which twists some of the fat molecules straight. Cows and sheep make a different, small amount naturally through the bacteria in their stomachs, and it shows up in dairy and meat.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Industrial trans isomers begin as liquid vegetable oil, typically soybean, cottonseed or rapeseed. Ruminant trans isomers begin as the unsaturated fat in forage and grain eaten by cattle, sheep and goats.
In a plant, hydrogen gas is bubbled through heated oil over a nickel catalyst and the reaction is halted before saturation is complete, isomerising some remaining double bonds to the trans configuration. In an animal, rumen bacteria hydrogenate dietary unsaturated fat and release trans intermediates that pass into milk and body fat.
Processed oil is refined to remove catalyst residue, free fatty acids and colour. High-temperature deodorising can itself isomerise a small further fraction of double bonds.
Gas chromatography with a long polar capillary column separates positional and geometric isomers, which is how a declared trans figure is generated for a fat.
Most trans fatty acid intake arrives inside a bulk fat rather than as an isolated compound. Purified single isomers exist mainly as analytical standards and as conjugated linoleic acid supplement preparations.
Getting Trans Fatty Acids from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Different dietary fatty acid supplements shifted the fatty acid profile of milk and the physical characteristics of butter made from it, with the fat source setting which isomers appeared.Animal study. Landry et al., 2026 (Journal of Dairy Science). PMID 42480920 ↗
- A blend of essential oils, tannins and bioflavonoids fed to dairy animals was associated with changes in milk yield and in the nutritional fatty acid profile of the milk.Animal study. Dibennardo et al., 2026 (Animals). PMID 42278083 ↗
- Alpha-lipoic acid, sprouted wheat and multi-enzyme supplementation altered the yolk fatty acid profile and antioxidant measures, showing that dietary fat composition transfers into the edible product.Animal study. Fazlollah et al., 2026 (Poultry Science). PMID 42176580 ↗
- The review of dietary interventions and skin ageing measures names dietary fat composition among the intake variables assessed across the included trials.Systematic review. Ng et al., 2025 (Journal of Physiological Anthropology). PMID 41174715 ↗
These are the studies our verdict leans on, chosen from the 4 we read for Trans Fatty Acids. The full linked list is below.
The studies, linked.
4 sources behind our Trans Fatty Acids verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialRandomized-controlled Trial to Assess the Effects of Different Trans-fatty Acids on Endothelial Function in HumansClinicalTrials.gov ↗NA · 142 participants · Terminated
- Clinical trialRationale, Study Design and Baseline Data of the TRANSQUAL Clinical Trial: A Study to Evaluate the Impact of Different Milk Fatty Acid Profiles on Cardiovascular Risk Factors in Healthy Volunteers; Focus on Trans Fatty AcidsClinicalTrials.gov ↗NA · 107 participants · Completed
- Clinical trialImpact of Trans Fatty Acids From Natural and Industrial Origin in the Induction of Insulin Resistance DevelopmentClinicalTrials.gov ↗NA · 66 participants · Completed
- Clinical trialThe Effects of Early Life Polyunsaturated Fatty Acids and Ruminant Trans Fatty Acids on Allergic Diseases: A Systematic Review and Meta-analysisClinicalTrials.gov ↗26 participants · Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.